Preventing and controlling influenza virus infection remains a global public health
challenge, as it causes seasonal epidemics to unexpected pandemics. These infections are …

Influenza is a major acute respiratory infection that causes mortality and morbidity
worldwide. Two classes of conventional antivirals, M2 ion channel blockers and …

Influenza viruses are a major threat to human health globally. In addition to further improving
vaccine prophylaxis, disease management through antiviral therapeutics constitutes an …

Influenza virus is a respiratory pathogen that can cause disease in humans, with symptoms
ranging from mild to life-threatening. The vast majority of influenza virus infections in …

Influenza has a long history of causing morbidity and mortality in the human population
through routine seasonal spread and global pandemics. The high mutation rate of the RNA …

Influenza is a contagion that has plagued mankind for many decades, and continues to pose
concerns every year, with millions of infections globally. The frequent mutations and …

Influenza A viruses cause significant morbidity and mortality annually, and the threat of a
pandemic underscores the need for new therapeutic strategies. Here, we briefly discuss …

Influenza viruses remain a constant burden in humans, causing millions of infections and
hundreds of thousands of deaths each year. Current influenza virus vaccine modalities …

Influenza virus infections are a major public health concern and cause significant morbidity
and mortality worldwide. Current influenza virus vaccines are an effective countermeasure …

Highlights•Resistance and timely treatment are challenges for approved influenza
antivirals.•Structure insights on RNP functional domains aid development of novel …